Dual positivity of hepatitis B surface antigen and anti-hepatitis C virus antibody and associated factors among apparently healthy patients of Ekiti State, Nigeria

Viral Immunology

Volumn 25, Issue 6, 2012, Pages 448-455

  Oje, Opeyemi James ^a   Sule, Waidi Folorunso ^b   Famurewa, Diran ^c  

^a Federal Polytechnic Idah   (Nigeria)

^b OSUN STATE UNIVERSITY   (Nigeria)

^c EKITI STATE UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; AGE DISTRIBUTION; AGRICULTURAL WORKER; ARTICLE; BLOOD SAMPLING; CONDOM; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGERIA; SEXUAL INTERCOURSE; SEXUALITY; STRUCTURED QUESTIONNAIRE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; NIGERIA; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84871057357     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2012.0042     Document Type: Article

References (50)

1. Liu Z, and Hou J: Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection. Int J Med Sci 2006;357-362.
2. Wasfi OAS, and Sadek NA: Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt. Eastern Mediterranean Health J 2011;17:238-242.
3. Mansour-Ghanael F, Fallah M-S, Jafarshad R, Joukar F, Salari A, and Tavafzadeh R: Prevalence of Hepatitis B surface antigen and hepatitis C virus antibody and their risk factors among Guilan's volunteer blood donors (1998-2003). Hepatitis Monthly 2007;7:239-241.
4. Ugbebor O, Aigbirior M, Osazuwa F, Enabudoso E, Zabayo O, and Ewing GW: The prevalence of hepatitis B and C viral infections among pregnant women. North Am J Med Sci 2011;3:238-241.
5. Bhatti MS, Quraishi M, Mahmood CZ, and Javaid K: Seroprevalence of HBsAg and HCV antibodies in healthy individuals of high socioeconomic status. E:/Biomedica 2007; 23:131-133.
6. Pennap GR, Yakubu A, Oyige O, and Forbi J: Prevalence of hepatitis B and C virus infection among people of a local community in Keffi, Nigeria. Afr J Microbiol Res 2010;4: 274-278.
7. Nystrom J: Functional role of T-cell activation in viral hepatitis. Department of Laboratory Medicine, Karolinska Institutet, Stocholm, Sweden, Thesis, 2009, pp 1-65.
8. Bigger CB, Brasky KM, and Lanford RE: DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 2001;75:7059-7066. (Pubitemid 32641593)
9. Thimme R, Bukh J, Spangenberg HC, et al.: Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci USA 2002;99: 15661-15668. (Pubitemid 35403988)
10. Wieland S, Thimme R, Purcell RH, and Chisari FV: Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA 2004;101:6669-6674. (Pubitemid 38586032)
11. Su AI, Pezacki JP, Wodicka L, et al.: Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA 2002;99:15669-15674. (Pubitemid 35403989)
12. Shen L, and Rock KL: Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. Curr Opin Immunol 2006;18:85-91. (Pubitemid 43049653)
13. Corr M, Lee DJ, Carson DA, and Tighe H: Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 1996;184:1555-1560. (Pubitemid 26354713)
14. Maini MK, Boni C, Lee CK, et al.: The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus (HBV) infection. J Exp Med 2000; 191:1269-1280. (Pubitemid 30227116)
15. Hepatitis C Support Project: HBV: how to interpret hepatitis B antibody and viral tests, 2008, www.hbvadvocate.org
16. Strader DB, Wright T, Thomas DL, and Seeff LB: Diagnosis, management, and treatment of hepatitis C. Hepatology 2004;39:1147-1171. (Pubitemid 38428955)
17. Gerlich WH: Diagnostic problems caused by HBs Ag mutants: A consensus report of an expert meeting. Intervirology 2004;47:310-313. (Pubitemid 39541276)
18. Locarnini S: Molecular virology of hepatitis B virus. Semin Liver Dis 2004;24(Suppl 1):3-10. (Pubitemid 38738352)
19. Jafri W, Jafri N, Yakoob J, et al.: . Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan. BMC Infect Dis 2006;23:101.
20. Bini EJ, and Perumalswami PV: Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: Prevalence, racial/ethnic differences, and viral interactions. Hepatology 2010;51:759-766.
21. Gaeta GB, Stornaiuolo G, Precone DF, et al.: Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J Hepatol 2003; 39:1036-1041. (Pubitemid 37523777)
22. Di Marco V, Lo Iacono O, Cammà C, et al.: The long-term course of chronic hepatitis B. Hepatology 1999;30:257-264. (Pubitemid 29300594)
23. Chen X, Xuan M, and Wu D: Study of superinfection of HBV and HCV. Zhonghua Liu Xing Bing Xue Za Zhi 1999;20: 141-143.
24. Fejza H, and Telaku S: Prevalence of HBV and HCV among blood donors in Kosovo. Virol J 2009;6:21.
25. Rajesh R, Subramaniam K, Padmavathy BK, Vasanthi S, and Uma S: Seroprevalence of HBV/HCV among STD clinic attendees in the era of HIV/AIDS. Indian J Sex Transm Dis 2006;27:56-60.
26. Pallas JR, Farinas-Alvarez C, Prieto D, and Delgado-Rodriguez M: Coinfections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users. Eur J Epidemiol 1999; 15:699-704. (Pubitemid 29493108)
27. Reddy GA, Dakshinamurthy KV, Neelaprasad P, Gangadhar T, and Lakshmi V: Prevalence of HBV and HCV dual infection in patients on haemodialysis. Indian J Med Microbiol 2005;23:41-43. (Pubitemid 40347433)
28. Aroldi A, Lampertico P, Montagnino G, et al.: Natural history of hepatitis B and C in renal allograft recipients. Transplantation 2005;79:1132-1136. (Pubitemid 40664010)
29. Kalinowska-Nowak A, Bociaga-Jasik, Garlicki A, and Skwara P: Prevalence of hepatotropic viruses HBV and HCV in HIV-infected patients from southern region of Poland. Acta Virologica 2000;44:23-28.
30. Irshad M, Peter S: Spectrum of viral hepatitis in thalassemic children receiving multiple blood transfusions. Indian J Gastroenterol 2002;21:183-184.
31. Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, and Chu CM: Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 2004;126:1024-1029.
32. Crespo J, Lozano JL, de la Cruz F, et al.: Prevalence and significance of hepatitis C viraemia in chronic active hepatitis B. Am J Gastroenterol 1994;89:1147-1151. (Pubitemid 24245785)
33. Sato S, Fujiyama S, Tanaka M, et al.: Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 1994;21:159-166. (Pubitemid 24270539)
34. Dai CY, Yu ML, Chuang WL, et al.: Influence of hepatitis C virus on the profiles of patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol 2001;16:636-640.
35. Semnani S, Roshandel G, Abdolahi N, et al.: Hepatitis B/C virus co-infection in Iran: a seroepidemiological study. Turk J Gastroenterol 2007;18:20-21. (Pubitemid 351676946)
36. Gogos CA, Fouka KP, Nikiforidis G, et al.: Prevalence of hepatitis B and C virus infection in the general population and selected groups in south-western Greece. Eur J Epidemiol 2003;18:551-557. (Pubitemid 36899560)
37. Cohan N, Zandieh T, Samiei SH, Ataie Z, and Kavari M: The prevalence and clinical significance of hepatitis B and C coinfection. Iran J Med Sci 2006;31:156-158. (Pubitemid 44510660)
38. Mehmet D, Meliksah E, Serif Y, Gunay S, Tuncer O, and Zeynep S: Prevalence of hepatitis B infection in the southern region of Turkey: Comparison of risk factors for HBV infection in rural and urban areas. Jpn J Infect Dis 2005;58:15-19. (Pubitemid 40425365)
39. Donovan B: Sexually transmissible diseases other than HIV. Lancet 2004;363:545-556. (Pubitemid 38229458)
40. Ophori EA, Wagbasoma A, and Atanunu O: Seroprevalence of hepatitis B virus (HBV) among pregnant women in Central Hospital, Warri, Delta State. Nig J Microbiol 2004;18: 217-221.
41. Alter MJ, Kruszon-Moran D, Nainan OV, et al.: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-562. (Pubitemid 29384163)
42. Ho MS, Hsu CP, Yuh Y, et al.: High rate of hepatitis C virus infection in an isolated community: Persistent hyperendemicity or period-related phenomena J Med Virol 1997;52:370-376. (Pubitemid 27356181)
43. Motta-Castro ARC, Yoshida CFT, Lemos ERS, et al.: Seroprevalence of hepatitis B virus infection among Afrodescendant community in Brazil. Mem Inst Oswaldo Cruz 2003;98:13-17. (Pubitemid 38019649)
44. Darwish MA, Khalil AH, Yassin MM, and Awad IF: Prevalence of HCV and HBV antibodies among intravenous drug adults and associated risk factors. Egypt J Med Lab Sci 2005;14.
45. El-Raziky MS, El-Hawary M, Esmat G, et al.: Prevalence and risk factors of asymptomatic hepatitis C virus infection in Egyptian children. World J Gastroenterol 2007;13: 1828-1832. (Pubitemid 46706017)
46. Olubuyide IO, Ola SO, Aliyu B, et al.: Hepatitis B and C in doctors and dentists in Nigeria. Q J Med 1997;90:417-422. (Pubitemid 27254198)
47. Al-Faleh FZ, Ayoola EA, Arif M, et al.: Seroepidemiology of hepatitis B virus infection in Saudi Arabian children: a baseline survey for mass vaccination against hepatitis B. J Infect 1992;24:197-206.
48. Okonko IO, and Udeze AO: Detection of hepatitis B surface antigen (HBsAg) among pregnant women attending antenatal clinic at O.L.A. Catholic Hospital, Oluyoro, Ibadan, Oyo State, Southwestern Nigeria. Nature Sci 2011;9:54-60.
49. Tapko JB, Mainuka P, and Diarra-Nama A: Status of blood safety in the WHO African region: Report of the 2004 survey. Brazzaville, World Health Organization Regional Office for Africa, 2009.
50. Mocroft A, Neuhaus J, Peters L, et al.: Hepatitis B and C coinfection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. PLoS One 2012;7:e40245.